1 / 5

Biopharmaceutical Contract Manufacturing Market Growth and Forecast to 2029

Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues, and living cells used in cell therapy. Many companies outsource the manufacturing of biopharmaceuticals due to a lack of manufacturing capabilities or in order to reduce the cost of the manufacturing process.

shristis030
Download Presentation

Biopharmaceutical Contract Manufacturing Market Growth and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biopharmaceutical Contract Manufacturing Market (2023-29)

  2. Market Overview: Global biopharmaceutical contract manufacturing market size was valued at USD 16.2 billion in 2022 and is expected to reach USD 23.57 billion by 2029 at a CAGR of 5.5% during the forecast period 2023 to 2029. The biopharmaceutical contract manufacturingresearch report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of thebiopharmaceutical contract manufacturinganalysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description

  3. Market Segments: The biopharmaceutical contract manufacturing markethas been fragmented based on: 1. By Manufacturing Process: Mammalian Based, Microbial Based, Insect Based, Plant Based, Yeast Based, Others 2. By Type Of Service: Formulation, Fill and Finish services, Cell Banking, Analytical Services, Process development, Others 3. By Molecule Type: Large Molecules, Small Molecules. 4. By End-User: Biopharmaceutical Companies, Pharmaceutical Companies, Research Organizations, Others 5. By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report

  4. Key Players: Some of the major key players in the biopharmaceutical contract manufacturing marketare: Lonza Group Ltd. (Switzerland) Boehringer Ingelheim GmbH (Germany) Charles River Laboratories, Inc. (U.S) Novartis AG (Switzerland) WuXiAppTec Group (China) Rentschler Biotechnologie GmbH (Germany) Fujifilm Holdings Corporation (Japan) Celonic AG (Switzerland) BIOMEVA GmbH (Germany) Request Sample Report

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553

More Related